Myriad Genetics
MYGN
#3881
Rank
ยฃ1.95 B
Marketcap
ยฃ21.56
Share price
-0.63%
Change (1 day)
54.18%
Change (1 year)

Revenue for Myriad Genetics (MYGN)

Revenue in 2024 (TTM): ยฃ0.63 B

According to Myriad Genetics's latest financial reports the company's current revenue (TTM) is ยฃ0.61 B. In 2023 the company made a revenue of ยฃ0.59 B an increase over the revenue in the year 2022 that were of ยฃ0.56 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Myriad Genetics from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.63 B8.08%
2023 ยฃ0.59 B5.43%
2022 ยฃ0.56 B9.89%
2021 ยฃ0.51 B
2019 ยฃ0.61 B-1.88%
2018 ยฃ0.62 B10.5%
2017 ยฃ0.56 B-7.1%
2016 ยฃ0.60 B20.9%
2015 ยฃ0.50 B8.09%
2014 ยฃ0.46 B4.33%
2013 ยฃ0.44 B32.35%
2012 ยฃ0.33 B18.31%
2011 ยฃ0.28 B16.31%
2010 ยฃ0.24 B13.89%
2009 ยฃ0.21 B-19.66%
2008 ยฃ0.26 B179.35%
2007 ยฃ95.88 M41.74%
2006 ยฃ67.65 M18.44%
2005 ยฃ57.12 M68.1%
2004 ยฃ33.97 M1.09%
2003 ยฃ33.61 M-9.72%
2002 ยฃ37.23 M10.05%
2001 ยฃ33.83 M21.25%
2000 ยฃ27.9 M54.6%
1999 ยฃ18.04 M27.7%
1998 ยฃ14.13 M9.51%
1997 ยฃ12.9 M148.29%
1996 ยฃ5.19 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ1.95 B 219.45%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.99 B 225.61%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ2.62 M-100.43%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.97 B 222.66%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ31.03 B 4,976.66%๐Ÿ‡บ๐Ÿ‡ธ USA